Why the study?
Non-invasive transcutaneous vagus nerve stimulation offers therapeutic potential for cognitive decline and aging populations, motivating a review of its cognitive and neurocardiovascular effects.
Does transcutaneous vagus nerve stimulation improve cognitive performance and neurocardiovascular stability in aging populations and those with cognitive decline?
Does transcutaneous vagus nerve stimulation improve cognitive performance and neurocardiovascular stability in aging populations and those with cognitive decline?
Transcutaneous vagus nerve stimulation presents a promising non-invasive therapeutic approach for improving cognitive function and neurocardiovascular stability in aging populations.
Supports hypothesis generation for t-VNS in cognitive decline; leaves open clinical adoption pending randomized trials.
The vagus nerve is the longest nerve in the human body, providing afferent information about visceral sensation, integrity and somatic sensations to the CNS via brainstem nuclei to subcortical and cortical structures. Its efferent arm influences GI motility and secretion, cardiac ionotropy, chonotropy and heart rate variability, blood pressure responses, bronchoconstriction and modulates gag and cough responses via palatine and pharyngeal innervation. Vagus nerve stimulation has been utilized as a successful treatment for intractable epilepsy and treatment-resistant depression, and new non-invasive transcutaneous (t-VNS) devices offer equivalent therapeutic potential as invasive devices without the surgical risks. t-VNS offers exciting potential as a therapeutic intervention in cognitive decline and aging populations, classically affected by reduced cerebral perfusion by modulating both limbic and frontal cortical structures, regulating cerebral perfusion and improving parasympathetic modulation of the cardiovascular system. In this narrative review we summarize the research to date investigating the cognitive effects of VNS therapy, and its effects on neurocardiovascular stability.
No takes yet. Share an insight, caveat, or question.
Dolphin et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: